These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 9501247)

  • 1. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.
    Uzunova V; Sheline Y; Davis JM; Rasmusson A; Uzunov DP; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3239-44. PubMed ID: 9501247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?
    Guidotti A; Costa E
    Biol Psychiatry; 1998 Nov; 44(9):865-73. PubMed ID: 9807641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.
    Agis-Balboa RC; Guidotti A; Pinna G
    Psychopharmacology (Berl); 2014 Sep; 231(17):3569-80. PubMed ID: 24781515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake.
    Pinna G; Costa E; Guidotti A
    Psychopharmacology (Berl); 2006 Jun; 186(3):362-72. PubMed ID: 16432684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake.
    Pinna G; Costa E; Guidotti A
    Curr Opin Pharmacol; 2009 Feb; 9(1):24-30. PubMed ID: 19157982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
    Dalery J; Honig A
    Hum Psychopharmacol; 2003 Jul; 18(5):379-84. PubMed ID: 12858325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
    Sheline Y; Bardgett ME; Csernansky JG
    J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD.
    Rasmusson AM; King MW; Valovski I; Gregor K; Scioli-Salter E; Pineles SL; Hamouda M; Nillni YI; Anderson GM; Pinna G
    Psychoneuroendocrinology; 2019 Apr; 102():95-104. PubMed ID: 30529908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
    J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.
    Griffin LD; Mellon SH
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13512-7. PubMed ID: 10557352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
    Nemeroff CB; Entsuah R; Benattia I; Demitrack M; Sloan DM; Thase ME
    Biol Psychiatry; 2008 Feb; 63(4):424-34. PubMed ID: 17888885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.
    Dell'Agnello G; Ceravolo R; Nuti A; Bellini G; Piccinni A; D'Avino C; Dell'Osso L; Bonuccelli U
    Clin Neuropharmacol; 2001; 24(4):221-7. PubMed ID: 11479393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss.
    Matsumoto K; Uzunova V; Pinna G; Taki K; Uzunov DP; Watanabe H; Mienville JM; Guidotti A; Costa E
    Neuropharmacology; 1999 Jul; 38(7):955-63. PubMed ID: 10428414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function.
    de Carvalho GA; Bahls SC; Boeving A; Graf H
    Thyroid; 2009 Jul; 19(7):691-7. PubMed ID: 19583486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis.
    Pinna G
    Behav Pharmacol; 2010 Sep; 21(5-6):438-50. PubMed ID: 20716970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.